Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

被引：0
|
作者：
Jo, S. H. [1 ]
Shim, H. S. [2 ]
Hong, J. Y. [1 ]
Kim, T. H. [2 ]
Cheon, D. Y. [1 ]
Kim, S. A. [1 ]
机构：
[1] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
    Tazkarji, Bachir
    Ganeshamoorthy, Ambika
    Auten, Beth
    AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
  • [2] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [3] Efficacy of Aliskiren for Patients with Hypertension Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin-Receptor Blockers
    Fujino, Noboru
    Araki, Tsutomu
    Yasuda, Toshihiko
    Terai, Hidenobu
    Konno, Tetsuo
    Sakata, Kenji
    Hayashi, Kenshi
    Kawashiri, Masaaki
    Ino, Hidekazu
    Yamagishi, Masakazu
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S157 - S157
  • [4] The Impact of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with Clostridium difficile infection
    Patel, Shilpa M.
    Stashefsky, Evan
    Maroun, Marie-Claire
    Johnson, Leonard B.
    MEDICAL HYPOTHESES, 2011, 76 (06) : 813 - 815
  • [5] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
    Ateya, Areej Mohamed
    Sabri, Nagwa A.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1873 - 1874
  • [6] Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress
    Baykal, Y
    Yilmaz, MI
    Celik, T
    Gok, F
    Rehber, H
    Akay, C
    Kocar, IH
    JOURNAL OF HYPERTENSION, 2003, 21 (06) : 1207 - 1211
  • [7] ANGIOTENSIN RECEPTOR BLOCKERS VS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN HYPERTENSIVE PATIENTS WITH SYSTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION
    Joo, S.
    Lee, J-G.
    Beom, J. W.
    Choi, J-H.
    Kim, S-Y.
    Kim, K-S.
    Rha, S. W.
    Jeong, J-O.
    Chae, S. C.
    Choi, D-J.
    Park, J. S.
    Jeong, M. H.
    JOURNAL OF HYPERTENSION, 2019, 37 : E82 - E82
  • [8] Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or beta-blockers for treating hypertension
    Bisognano, John D.
    McLaughlin, Trent
    Roberts, Craig S.
    Tang, Simon S. K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 579 - 585
  • [9] Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients
    Martin Wawruch
    Veronika Slezakova
    Jan Murin
    Jan Luha
    Michal Bozik
    Tatiana Leitmann
    Magdalena Kuzelova
    Rashmi Shah
    Aging Clinical and Experimental Research, 2014, 26 : 307 - 314
  • [10] Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients
    Wawruch, Martin
    Slezakova, Veronika
    Murin, Jan
    Luha, Jan
    Bozik, Michal
    Leitmann, Tatiana
    Kuzelova, Magdalena
    Shah, Rashmi
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 26 (03) : 307 - 314
12345